A BRAVE
A-BRAVE: Phase III Trial of Adjuvant Avelumab vs Observation in Patients With Early TNBC With Residual Disease Post Neoadjuvant CT or at High Risk After Surgery and Adjuvant CT

Released: June 07, 2024

Expiration: June 06, 2025

Activity

Progress
1
Course Completed